Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Matrices
Patent
1992-08-14
1993-12-07
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Matrices
424468, 424469, 424470, 424486, 424494, 424495, 424497, 424498, 424499, 424501, 424502, 514254, 514929, A61K 914, A61K 926, A61K 31505
Patent
active
052681823
ABSTRACT:
A sustained-release coating composition is described that contains an ethylcellulose and/or a methacrylic methylester together with a plasticizer and a detackifying agent. Sized drug granules are coated with this composition and then mixed with a polymeric composition containing at least one viscosity agent and formed into drug dosage units for the administration and sustained release of the drug in a patient.
The sustained-release drug dosage units described produce a continuous, slow release of the drug at a therapeutically effective dosage level when administered to a patient.
REFERENCES:
patent: 4138475 (1979-02-01), McAinsh et al.
patent: 4199560 (1980-04-01), Gyarmati et al.
patent: 4252786 (1981-02-01), Weiss et al.
patent: 4351825 (1982-09-01), Sothmann et al.
patent: 4555399 (1985-11-01), Hsiao et al.
patent: 4572833 (1986-02-01), Pedersen et al.
patent: 4713248 (1987-12-01), Kjornaes et al.
patent: 4716041 (1987-12-01), Kjornaes et al.
patent: 4748023 (1988-05-01), Tamas et al.
patent: 4756911 (1988-07-01), Drost et al.
patent: 4772475 (1988-09-01), Fukui et al.
patent: 4786506 (1988-11-01), Fontanelli
patent: 4800087 (1989-01-01), Mehta et al.
patent: 4828840 (1989-05-01), Sakamoto et al.
patent: 4874614 (1989-10-01), Becker et al.
patent: 4913906 (1990-04-01), Friedman et al.
patent: 4925675 (1990-05-01), Giannini et al.
patent: 4942040 (1990-07-01), Ragnarsson et al.
patent: 4957745 (1990-09-01), Jonsson et al.
Brinker Dale R.
Eveline Enrique D.
Abbott Laboratories
Crowley Steven R.
Page Thurman K.
Spear James M.
LandOfFree
Sustained-release drug dosage units of terazosin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained-release drug dosage units of terazosin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained-release drug dosage units of terazosin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2014454